SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-18-002283
Filing Date
2018-08-14
Accepted
2018-08-14 09:15:14
Documents
3
Period of Report
2018-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT rxi_8k-081418.htm 8-K 20430
2 PRESS RELEASE rxi_8k-ex9901.htm EX-99.1 55415
3 GRAPHIC image_001.jpg GRAPHIC 2930
  Complete submission text file 0001683168-18-002283.txt   81164
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 181014601
SIC: 2834 Pharmaceutical Preparations